Related Experiment Video
Updated: May 16, 2025

A Protocol for the Administration of Real-Time fMRI Neurofeedback Training
Published on: August 24, 2017
[The potential of neurofeedback control in treating insomnia and improving sleep quality (a systematic review)]
A V Zakharov1, I V Shirolapov1
1Samara State Medical University, Samara, Russia.
Abstract:
Chronic sleep disturbance has a pronounced adverse impact on a person's quality of life and physical and mental well-being. Despite the high prevalence of the disorder and the need for therapeutic interventions, the accessibility and effectiveness of conventional insomnia treatments remain limited. The electroencephalography (EEG)-neurofeedback control method is based on objective brain activity data to teach the patient self-regulation. This study performed a systematic analysis of current data on the use of neurofeedback technology for the treatment of sleep disorders, assessing the method's effectiveness and limitations. The search and review of publications from international databases over the past 10 years was performed in accordance with the PRISMA guidelines and the methods described in the RELISH Consortium. The results show that neurofeedback control, in particular, based on individual peak alpha frequency, is a viable and promising therapy. The technology significantly improves subjective and objective sleep parameters, such as reducing sleep latency, increasing total sleep time, and improving sleep quality. With its high efficacy and safety, neurofeedback control can become one of the key components of personalized medicine for the long-term treatment of insomnia and other sleep disorders.
Related Concept Videos
Management of Insomnia
Insomnia
Multiple factors contribute...
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...
Sleep-Wake Cycles
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Narcolepsy

